Navigation Links
NeoStem's Suzhou Erye Pharmaceutical Receives Two Awards at the Chempharm Brand Summit 2011
Date:4/26/2011

NEW YORK, April 26, 2011 /PRNewswire/ -- NeoStem, Inc. ("NeoStem" or the "Company") (NYSE Amex: NBS), an international biopharmaceutical company with operations in the U.S. and China, today announced that its majority owned Suzhou Erye Pharmaceutical Company Ltd. subsidiary ("Erye Pharmaceutical") received two awards at the Chempharm Brand Summit 2011 in China.

During the 4th Chempharm Brand Summit held in Chengdu city from April 21st - 23rd, 2011, select recipients in the pharmaceutical industry were recognized by industry leaders with awards to reward outstanding achievement in specific categories.  Erye Pharmaceutical was awarded "Top 10 Anti-Infection Drug Award" and "Top 100 Brand Names Award".  

Madame Jian Zhang, Erye Pharmaceutical's General Manager, commented, "We are honored to have received such awards at the Chempharm Brand Summit and believe that our business will expand as we continue to transition to our new manufacturing facility."

Erye expects to be fully transitioned to its new 53,000 square meter state-of-the-art manufacturing facility this year.  This facility was built to be compliant with State Food and Drug Administration (SFDA) regulations and the latest current Good Manufacturing Practices (cGMP) global standards.  Approval (SFDA – Certificate of Approval) of the lyophilized (freeze dried) powder for injection production line is expected shortly.  Two additional production line approvals at the new plant (the oral active pharmaceutical ingredient (API) line and the capsule line) are expected by year end.  Omeprazole for GERD was launched in 2010 and is currently being manufactured at the new plant.  Production of the sterile API cloxacillin sodium which was approved in 2010 is scheduled to be launched and in production at the new facility once the cGMP line receives final SFDA approval. Erye Pharm
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
2. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
3. Protect Pharmaceutical Corporation Appoints Chief Executive Officer and Chief Financial Officer
4. Reportlinker Adds Pharmaceutical Key Trends 2011 - Pharmaceutical Industry Infrastructure Overview: Pharma innovates, diversifies and contains cost in order to grow profits
5. Simcere Pharmaceutical Group to Announce First Quarter 2011 Financial Results on Tuesday, May 10, 2011
6. HemaQuest Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Study of HQK-1001 in Patients With Sickle Cell Disease
7. New Biopharmaceutical Company to Accelerate Delivery of Vaccines and Protein Therapeutics
8. Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
9. Pharmaceutical Medical Affairs Functions Get a Boost in Budget, Staffing
10. Cumberland Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 4, 2011
11. Valeant Pharmaceuticals Responds to Cephalon Boards Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 China Biologic Products, Inc. (NASDAQ: ... integrated plasma-based biopharmaceutical company in China ... third quarter 2014 financial results on Wednesday, November 5, ... Company,s management will hold a conference call at 7:30 ... is 8:30 p.m., Beijing Time on November 6, 2014, ...
(Date:10/30/2014)... , La fórmula de ... adquirir tolerancia a la proteína de leche de ... la leche de la vaca (APLV) es la principal alergia ... la APLV se trataba eliminando las proteínas lácteas ... es posible adquirir tolerancia oral en un número ...
(Date:10/30/2014)... YORK , Oct. 29, 2014 ... the basis of test type, technology, product, and ... register the highest growth rate in the newborn ... This high growth is attributed to various nations ... is a fundamental instrument used for expanded newborn ...
Breaking Medicine Technology:China Biologic to Report Third Quarter 2014 Financial Results 2Según expertos reunidos en el Simposio Allergy Day 2Según expertos reunidos en el Simposio Allergy Day 3NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 2NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 3
... 23, 2011 GeoVax Labs, Inc. (OTC Bulletin Board: ... of Phase 1 clinical trial testing of its HIV/AIDS vaccine ... of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 ... The Journal of Infectious Diseases . A ...
... 23, 2011 Cardiogenesis Corporation (Pink Sheets: CGCP ... fourth quarter and full-year ended December 31, 2010 on Wednesday, ... its Executive Chairman, and William R. Abbott, its Senior Vice ... call that day at 5:00 p.m. Eastern time (2:00 p.m. ...
Cached Medicine Technology:GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 2GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 3GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 4Cardiogenesis Corporation to Report 2010 Fourth Quarter and Full-Year Results on March 9th 2
(Date:10/30/2014)... Jacksonville, FL (PRWEB) October 30, 2014 ... non-profit offering therapeutic horseback riding to special needs individuals ... Annual Round-Up on Saturday, November 15 from 10-2:00 p.m. ... fun event is open to the public and is ... programs. , Admission to the HSS Round-Up is ...
(Date:10/30/2014)... California (PRWEB) October 30, 2014 REV'D ... bars are now available through a unique service called, ... site designed to empower the everyday athlete. The Feed ... best athletes and created a system to pass that ... to see REV’D® is now available on The Feed!” ...
(Date:10/30/2014)... October 30, 2014 Victory Healthcare, ... its 2014 third quarter infection rates and patient ... infection rates of only two percent or less, ... scores exceeding 98 percent. , “We are delighted ... included rising satisfaction scores,” said Robert Helms, chairman ...
(Date:10/30/2014)... News) -- Scientists who used stem cells to create ... could provide a new way to learn more about ... team used human pluripotent stem cells -- which can ... to grow the functional miniature stomachs, to study infection ... of ulcers and stomach cancer. The miniature stomachs ...
(Date:10/30/2014)... -- Many U.S. colleges have indoor tanning salons ... the risk for skin cancer, researchers report. ... women, so colleges should adopt tanning-free policies, to ... "Public health efforts are needed to raise university ... that indoor tanning poses to young adults in ...
Breaking Medicine News(10 mins):Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 2Health News:Victory Healthcare Releases Q3 Satisfaction, Infection Rates 3Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... University of Michigan Health System-led team of researchers has found ... the most serious complications in patients with leukemia, lymphoma and ... blood-forming cells. Known as a hematopoietic stem cell transplant, ... from a matched donor who is either a family member ...
... Research Hospital scientists advances a strategy for taming the ... and other medications that work by disrupting the activity ... small molecule developed at St. Jude. In this study, ... blocked the activity of genes in a cell signaling ...
... endoprosthetic joint replacement in patients with osteoarthritis. Henning ... current issue of Deutsches rzteblatt International ... cartilage defects often develop subsequent to injury or ... overview of currently available medical and surgical therapeutic ...
... Magnetic resonance imaging (MRI) is an established technique which over ... professionals to study biological phenomena in the body without using ... by normal MRI are, to put it simply, pictures of ... up of water. MRI produces images of the hydrogen nuclei ...
... HealthDay Reporter , THURSDAY, Oct. 20 (HealthDay ... have many more accidents than adults have zeroed in ... braking late, swerving abruptly and other common new-driver mistakes. ... likely and leave less time to react to hazards, ...
... of people who were suicidal has highlighted the main challenges they ... and decide what they should do about it. The ... College of Medicine and Dentistry, supported by Devon NHS Partnership Trust ... published in the British Medical Journal on 22nd October ...
Cached Medicine News:Health News:Biomarker detects graft-versus-host-disease in cancer patients after bone marrow transplant 2Health News:Research involving thyroid hormone lays foundation for more targeted drug development 2Health News:Research involving thyroid hormone lays foundation for more targeted drug development 3Health News:New instrument helps researchers see how diseases start and develop in minute detail 2Health News:Teen Drivers Prone to 'G-Force' Errors, Researchers Say 2Health News:Teen Drivers Prone to 'G-Force' Errors, Researchers Say 3Health News:Study highlights issues faced by friends and family of the suicidal 2
Straight shafts with polished finish. Teeth: 0.12 mm. Tying platform: 5.0 mm. Wide Serrated....
Angled 45 degree shafts with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Straight shafts with 1 x 2 teeth and 6 mm tying platform. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth and serrated handle with polished finish....
Medicine Products: